Alan P. Knutsen

Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report

Outcomes following matched sibling donor transplantation for severe combined immunodeficiency: a report from the PIDTC

Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium

Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGD

Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark study

The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions

Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency

Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers

Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT

SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery

The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)

Immune reconstitution and survival of 100 SCID patients post–hematopoietic cell transplant: a PIDTC natural history study

Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation

Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009

The Natural History of Children with Severe Combined Immunodeficiency: Baseline Features of the First Fifty Patients of the Primary Immune Deficiency Treatment Consortium Prospective Study 6901

Fungi and allergic lower respiratory tract diseases